GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Life Science Corp (XKRX:234080) » Definitions » Total Equity

JW Life Science (XKRX:234080) Total Equity : ₩200,445 Mil (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is JW Life Science Total Equity?

JW Life Science's total equity for the quarter that ended in Dec. 2024 was ₩200,445 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

JW Life Science Total Equity Historical Data

The historical data trend for JW Life Science's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Life Science Total Equity Chart

JW Life Science Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 132,493.88 131,492.02 140,332.44 159,393.12 200,444.75

JW Life Science Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 159,393.12 156,783.87 163,440.84 170,202.74 200,444.75

JW Life Science Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

JW Life Science's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=325323.614-124878.866
=200,445

JW Life Science's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=325323.614-124878.866
=200,445

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JW Life Science Total Equity Related Terms

Thank you for viewing the detailed overview of JW Life Science's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

JW Life Science Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Life Science Corp (XKRX:234080) » Definitions » Total Equity
Comparable Companies
XKRX:016580 XKRX:000020 XKRX:271980 XKRX:293780 XKRX:092040 XKRX:002390 XKRX:032300 XKRX:008490 XKRX:011040 XKRX:023910 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
28, Hanjin 1-gil, Songak-eup, Dangjin-si, Chungcheongnam-do, Seoul, KOR, 343-823
Website
http://www.jw-lifescience.co.kr
JW Life Science Corp develops and produces infusion solutions. Its products contents amino acids, lipids, proteins, vitamins, and minerals to patients.

JW Life Science Headlines

No Headlines